Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop.

ABSTRACT:

Background

Oligodendroglioma is a rare primary central nervous system (CNS) tumor with highly variable outcome and for which therapy is usually not curative. At present, little is known regarding the pathways involved with progression of oligodendrogliomas or optimal biomarkers for stratifying risk. Developing new therapies for this rare cancer is especially challenging. To overcome these challenges, the neuro-oncology community must be particularly innovative, seeking multi-institutional and international collaborations, and establishing partnerships with patients and advocacy groups thereby ensuring that each patient enrolled in a study is as informative as possible.

Methods

The mission of the National Cancer Institute's NCI-CONNECT program is to address the challenges and

SUBMITTER: Penas-Prado M 

PROVIDER: S-EPMC7212866 | biostudies-literature | 2020 Jan-Dec

REPOSITORIES: biostudies-literature